Project Grant HT94252411049
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
This $644,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the University of California, Davis in developing a PLZ4-targeting ultra-small DM1 nanoconjugate for bladder cancer therapy. The project aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research addressing critical health challenges. The award duration is from June 1, 2025...
The University of California, Davis was awarded a $442,750.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on February 1, 2025 with a completion date of January 31, 2027, will support research to determine the role of histone lactylation in post-traumatic osteoarthritis and arthritic pain. As a prominent public research university, UC Davis has demonstrated extensive capabilities in delivering...
The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,199,936.00 to the University of California, Davis to develop a point-of-care, scalable, long-acting nanoparticle anesthetic tilapia dressing for burn wound and pain management. The award period runs from July 1, 2025 to June 30, 2028. The University of California, Davis, a prominent public research university, will leverage its extensive scientific...
This federal Project Grant award of $321,981.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, Davis on "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism". The award period runs from April 1, 2025 to March 31, 2027 and aims to investigate medical solutions that can transform health care for military service members, veterans, and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,217,668.00 to the Medstar Health Research Institute Inc. for a research project titled "Toxic Products of Combustion in Burn and Smoke Inhalation Injuries". The performance period runs from September 1, 2024 through October 31, 2027. The Medstar Health Research Institute Inc., a non-profit healthcare research organization, will conduct...
This federal Project Grant award of $1,801,179.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the University of California, Davis aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "CONTRIBUTION OF BONE MASS AND FRACTURE TO BONE METASTASIS IN PROSTATE CANCER," will investigate innovative approaches to...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
This Project Grant award of $2,209,988.00 from the Defense Health Agency supports research by The Leland Stanford Junior University, doing business as Stanford University, to develop pharmacological approaches for protection and recovery from burn-associated inhalation injury. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. Over the award period from...